Regeneron Pharmaceuticals Inc (REGN) — Capital Reinvestment Ratio

Latest as of March 2026: 0.21x

Regeneron Pharmaceuticals Inc (REGN) has a Capital Reinvestment Ratio of 0.21x as of March 2026, meaning it reinvests 0% of its operating cash flow ($1.08 Billion) in capital expenditures ($230.60 Million). See REGN net asset quality index to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.21x
Capex / Operating Cash Flow

Operating Cash Flow

$1.08 Billion
USD

Capital Expenditures

$230.60 Million
USD

Data as of

Mar 2026
Most recent filing

Regeneron Pharmaceuticals Inc Capital Reinvestment Ratio (2006–2025)

This chart tracks Regeneron Pharmaceuticals Inc's Capital Reinvestment Ratio across 16 annual periods. Check REGN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for Regeneron Pharmaceuticals Inc (2006–2025)

Year-by-year Capital Reinvestment Ratio for Regeneron Pharmaceuticals Inc from 2006 to 2025. For live market cap and broader valuation context, see Regeneron Pharmaceuticals Inc market cap and net worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2025 0.18x $4.98 Billion $898.40 Million ▲ +5.5%
2024 0.17x $4.42 Billion $755.90 Million ▼ -15.2%
2023 0.20x $4.59 Billion $926.40 Million ▲ +71.4%
2022 0.12x $5.01 Billion $590.10 Million ▲ +51.0%
2021 0.08x $7.08 Billion $551.90 Million ▼ -66.8%
2020 0.23x $2.62 Billion $614.60 Million ▲ +32.8%
2019 0.18x $2.43 Billion $429.60 Million ▲ +1.3%
2018 0.17x $2.20 Billion $383.10 Million ▼ -16.3%
2017 0.21x $1.31 Billion $272.60 Million ▼ -39.5%
2016 0.34x $1.49 Billion $511.90 Million ▼ -32.4%
2015 0.51x $1.33 Billion $677.93 Million ▲ +15.1%
2014 0.44x $752.43 Million $333.01 Million ▲ +66.6%
2013 0.27x $588.60 Million $156.32 Million ▼ -74.3%
2010 1.03x $96.34 Million $99.69 Million ▲ +53.5%
2007 0.67x $27.37 Million $18.45 Million ▲ +453.2%
2006 0.12x $23.07 Million $2.81 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow